Scroll.in The Jan Vishwas Bill, 2023, passed by Lok Sabha on July 27, is in the news for its lenient approach to the crime of Manufacturing “not of standard quality” (NSQ) drugs. But comparatively less attention is being paid to the adverse impact that the legislation will have on an equally serious issue, which is the regulation of pharmacies that have a key role to play in India’s drug supply. To begin...
More »SEARCH RESULT
Poverty and inequality
KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »India posts GDP growth of 6.1 % in fourth quarter, 7.2 % in FY23 - The Tribune
India continues to maintain its streak of world-beating economic growth after GDP for the March quarter beat all expectations with a 6.1 per cent expansion that helped push the annual growth rate to 7.2 per cent. After this, the Indian economy is now USD 3.3 trillion in size. Asia’s third-largest economy beat all estimates to grow at 6.1 per cent in January-March, the last quarter of the 2022-23 fiscal, up from...
More »US FDA Flags Lapses by Indian Firm's Eye Drops Linked to Vision Loss and Deaths - Tabassum Barnagarwala
Scroll.in The US Food and Drug Administration has found a series of violations in the Manufacturing process and sterilisation methods adopted by Global Pharma, the Indian manufacturer of an eye drop that has been linked to 68 cases of eye infection in America, including eight cases of vision loss and three deaths. The company recalled its product, EzriCare Artificial Tears Eye Drop, early in February. The over-the-counter product has been linked to...
More »Oct-Dec Quarter GDP slows to 4.4% as Manufacturing shrinks - Tanya Krishna
Financial Express India's gross domestic product in the October-December, 2022 quarter is estimated to have grown at 4.4 percent year-on-year, slowing down from the previous two quarters, and a tad slower than expected, mainly as Manufacturing activity took a hit, and favourable base faded away, government data showed on Tuesday. India’s GDP at constant prices in Q3 of FY 2022-23 is estimated at Rs 40.19 lakh crore, the Ministry of Statistics...
More »